Publication detail
I/D ACE gene polymorphism in survival of leukemia patients - hypothesis and pilot study
HÁJEK, D. TOMISKA, M. KRAHULCOVÁ, E. DRUCKMÜLLER, M. FLORIÁNOVÁ, M. IZAKOVIČOVÁ-HOLLÁ, L. VÁCHA, J.
Czech title
I/D ACE gene polymorphism in survival of leukemia patients - hypothesis and pilot study
English title
I/D ACE gene polymorphism in survival of leukemia patients - hypothesis and pilot study
Type
journal article - other
Language
en
Original abstract
Angiotensin-I converting enzyme (ACE) is involved not only in intracellular volume regulation but also in proliferation control. Since both ACE gene polymorphism (I/D ACE) and ABO blood group determine ACE level in peripheral blood and probably also in bone marrow, the hypothesis to the interindividual differences in survival of leukemic patients was suggested.The data of 25 patients of both sexes with acute myelogenous (AML), acute lymphatic (ALL), chronic myelogenous (CML) and chronic lymphatic (CLL) leukemia treated by conventional were used for the study.The overall survival (SUR) was estimated as the time from the date of diagnosis to the date of death. The difference between patient's individual SUR (iSUR) and median SUR according to the type of leukemia (mSUR) was calculated. This difference (iSUR-mSUR) varied with I/D ACE genotype (p<0.02) but neither with diagnosis nor with ABO blood group. The regression model for iSUR calculation, from mSUR and I/D ACE genotype, has been suggested.
Czech abstract
Angiotensin-I converting enzyme (ACE) is involved not only in intracellular volume regulation but also in proliferation control. Since both ACE gene polymorphism (I/D ACE) and ABO blood group determine ACE level in peripheral blood and probably also in bone marrow, the hypothesis to the interindividual differences in survival of leukemic patients was suggested.The data of 25 patients of both sexes with acute myelogenous (AML), acute lymphatic (ALL), chronic myelogenous (CML) and chronic lymphatic (CLL) leukemia treated by conventional were used for the study.The overall survival (SUR) was estimated as the time from the date of diagnosis to the date of death. The difference between patient's individual SUR (iSUR) and median SUR according to the type of leukemia (mSUR) was calculated. This difference (iSUR-mSUR) varied with I/D ACE genotype (p<0.02) but neither with diagnosis nor with ABO blood group. The regression model for iSUR calculation, from mSUR and I/D ACE genotype, has been suggested.
English abstract
Angiotensin-I converting enzyme (ACE) is involved not only in intracellular volume regulation but also in proliferation control. Since both ACE gene polymorphism (I/D ACE) and ABO blood group determine ACE level in peripheral blood and probably also in bone marrow, the hypothesis to the interindividual differences in survival of leukemic patients was suggested.The data of 25 patients of both sexes with acute myelogenous (AML), acute lymphatic (ALL), chronic myelogenous (CML) and chronic lymphatic (CLL) leukemia treated by conventional were used for the study.The overall survival (SUR) was estimated as the time from the date of diagnosis to the date of death. The difference between patient's individual SUR (iSUR) and median SUR according to the type of leukemia (mSUR) was calculated. This difference (iSUR-mSUR) varied with I/D ACE genotype (p<0.02) but neither with diagnosis nor with ABO blood group. The regression model for iSUR calculation, from mSUR and I/D ACE genotype, has been suggested.
Keywords in English
chronic lymphatic leukemia
Released
01.07.2003
Publisher
Elsevier
Location
Spojené království
ISSN
0306-9877
Journal
Medical Hypotheses
Volume
2003
Number
1
Pages count
5
BIBTEX
@article{BUT43808,
author="Dobroslav {Hájek} and Miroslav {Tomiska} and Eva {Krahulcová} and Miloslav {Druckmüller} and Marie {Floriánová} and Ludmila {Izakovičová-Hollá} and Jan {Vácha},
title="I/D ACE gene polymorphism in survival of leukemia patients – hypothesis and pilot study",
journal="Medical Hypotheses",
year="2003",
volume="2003",
number="1",
month="July",
publisher="Elsevier",
address="Spojené království",
issn="0306-9877"
}